Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Ashwani Gujral of ashwanigujral.com recommends buying Divis Laboratories, Oriental Bank of Commerce, Supreme Infrastructure, Bharat Financial and Indiabulls Real Estate.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptualsian.com shared his views and outlook on the fundamentals of the markets and specific stocks.
Ashwani Gujral of ashwanigujral.com suggests buying Reliance Industries, Kotak Mahindra Bank and Divis Lab.
Ashish Kyal of Waves Strategy Advisors suggests buying BPCL with a target of Rs 690 and Mindtree with a target of Rs 570.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian shared his views and outlook on the fundamentals of the market ans specific stocks.
Vishal Malkan of malkansview.com advises selling Power Finance Corporation with target of Rs 115.
In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his readings and outlook on market and specific stocks.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian ofsptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.
In at interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his readings and outlook on the fundamentals of the market and specific stocks.
Hemant Thukral of Aditya Birla Money feels that Ujjivan Financial Services may test Rs 320-325.
Shahina Mukadam, Independent Market Expert is of the view that one may hold Divis Laboratories.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.
In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his readings and outlook on market and specific stocks.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his readings and outlook on the market and specific stocks.
According to Prakash Gaba of prakashgaba.com, Nifty has support at 9540 and resistance at 9660-9713 while Bank Nifty has support at 23000 and resistance at 23500.
Ashwani Gujral of ashwanigujral.com recommends buying Wockhardt, Divis Laboratories and Aurobindo Pharma.
In an interview to CNBC-TV18, Amey Chalke, Research Analyst at HDFC Securities shared his readings and outlook on a few of the pharma stocks.
According to Gaurang Shah of Geojit Financial Services, one may prefer Aurobindo Pharma.
Prakash Gaba of prakashgaba.com is of the view that one may hold Divis Laboratories for long term.
In an interview to CNBC-TV18’s Latha Venkatesh, Anuj Singhal, and Sonia Shenoy, SP Tulsian of sptulsian.com shared his readings and outlook on market and specific stocks.
Analysts' views on Kotak Mahindra Bank, IndusInd Bank, Divi's Laboratories as well as the media sector.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy YES Bank, Aditya Birla Nuvo and Bata India and sell M&M and Apollo Hospitals.
Ashwani Gujral of ashwanigujral.com is of the view that one can sell Hindustan Zinc and Bharat Financial Inclusion and buy Ceat while he feels that Reliance Capital may hit Rs 800.
Ashwani Gujral of ashwanigujral.com recommends buying Dewan Housing Finance Corporation, Amara Raja Batteries and Bharat Petroleum Corporation.